Biologic prescribing restrictions eased for severe asthma

PBS restrictions have been eased on prescribing of the biologics in severe asthma from 1 December. The PBS has adopted the following recommendation made by the Pharmaceutical Benefits Advisory Committee (PBAC) at its May meeting: Initial treatment: Amendment of the eosinophil cut-off from ≥ 300 cells per µL to 150 cells per µL for patients ...